The Role of Non-Statin Therapies for Management of ASCVD Risk

Presented by Dr. Paul Doghramji at PCN Destinations, this activity will review the latest guidelines and recommendations on cholesterol management, identify potential cholesterol-lowering therapies beyond statins and know when to utilize and recognize the indications for PCSK9 inhibitor therapy.

Primary Care Medicine: On Demand

This course features 20 sessions designed to update primary care clinicians in rapidly changing therapeutic areas. The emphasis is on practical and useful information for clinical practice. Topics include: Cardiology, Diabetes, Endocrinology, Gastroenterology, Hepatology, Infectious Disease, Nephrology, Psychiatry, Pulmonology, Rheumatology, and Women’s Health.

‘Tis the Season: Recognizing and Managing Post-Holiday Health Problems

Ah, the winter holidays: warm memories created when loving families get together to celebrate over home-cooked meals and pass down...

Acute Coronary Syndromes

This activity will provide the attendee with the latest up-to-date information and state-of-the-art management strategies using oral antiplatelet drugs for Acute Coronary Syndrome patients based on the 2013 ACC/AHA Guidelines.


The ACC/AHA guidelines has 9 recommendations for hypertension. Dr. Charles Sneiderman reviews the new guidelines published in 2014 by the National Institutes of Health eighth Joint National Committee (JNC8).

Heart Failure

Heart failure is an economic loss with almost thirty-two billion dollars spent annually to cover the expenses incurred due to this disease including medications for treatment, provision of health care, and work days lost. With careful attention to evidence based guidelines for care and comprehensive, holistic, and collaborative efforts made by providers, patients and payers, this challenging disease can be tackled both effectively and efficiently.

Renal Medication Dosing

Renal Medication Dosing. One of the most difficult propositions for practitioners is the adjustment of medications when dosing for Chronic Kidney Disease (CKD). This article serves to update the non-nephrology practitioner on the practical dosing of medications for the CKD patient in 2012.

Chronic Kidney Disease

Chronic Kidney Disease: A New Paradigm. Since diabetes and hypertension are diseases of aging, the increase in the number of CKD patients will continue for the foreseeable future. The Government’s Healthy People 2020 goals acknowledges the burden of CKD and encourages practitioners to aggressively treat these patients to attempt to lower the morbidity and mortality caused by CKD. This article highlights outcome-driven treatments that can assist the practitioner in accomplishing that goal.